Compound ID |
Cluster
|
Compound Type
|
Target/Cell | Structure | Activity | Assay Description | Source | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Type
|
Relation
|
Value
|
Unit
|
||||||||
NAs.002027 | 2 | all-match | Adenosine deaminase | ![]() |
Other | = | 160000.0 | nM | Michaelis rate constant is determined by the Lineweaver and Burk method against adenosine deaminase | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Unchecked | ![]() |
Other | > | 21.0 | % | Inhibitory effects on HSV-1 induced mortality in NMRI mice upon (ip) administration at a dose of 250 mk/kg/day | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Unchecked | ![]() |
Other | = | 16.0 | % | Inhibitory effects on HSV-1 induced mortality in NMRI mice upon (ip) administration at a dose of 100 mk/kg/day | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Unchecked | ![]() |
Other | = | 19.3 | % | Inhibitory effects on HSV-1 induced mortality in NMRI mice upon (ip) administration at a dose of 150 mk/kg/day | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Unchecked | ![]() |
Other | > | 21.0 | % | Inhibitory effects on HSV-1 induced mortality in NMRI mice upon (ip) administration at a dose of 250 mk/kg/day | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | CCRF-CEM | ![]() |
IC50 | > | 300.0 | ug.mL-1 | Cellular toxic effect was determined in CEM cells | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | MT4 | ![]() |
IC50 | = | 298.0 | ug.mL-1 | Cellular toxic effect was determined in MT-4 cells | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Unchecked | ![]() |
Other | = | 19.5 | % | Inhibitory effects on HSV-1 induced mortality in NMRI mice upon (ip) administration at a dose of 150 mk/kg/day | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Moloney murine sarcoma virus | ![]() |
IC50 | = | 17.0 | ug.mL-1 | Inhibition of antiviral activity against moloney murine sarcoma virus(MSV)in CEM cells in cell protection assay | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Human immunodeficiency virus 1 | ![]() |
IC50 | = | 5.9 | ug.mL-1 | Inhibition of cytopathogenicity against human HIV-1(IIIB) in MT-4 cells | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Phosphoribosyl pyrophosphate synthetase-associated protein 2 | ![]() |
Ki | = | 790000.0 | nM | Inhibitory activity against PRPP synthetase | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Phosphoribosyl pyrophosphate synthetase-associated protein 2 | ![]() |
Other | = | 12.0 | None | Maximum velocity constant of the rate of phosphorylation was determined against PRPP synthetase | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Phosphoribosyl pyrophosphate synthetase-associated protein 2 | ![]() |
Other | = | 570000.0 | nM | Michaelis rate constant is determined by the Lineweaver and Burk method against PRPP synthetase | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Adenosine deaminase | ![]() |
Ki | = | 100000.0 | nM | Inhibitory activity against adenosine deaminase | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Adenosine deaminase | ![]() |
Other | = | 9.8 | None | Maximum velocity constant of the rate of deamination was determined against adenosine deaminase | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Human immunodeficiency virus 2 | ![]() |
IC50 | = | 6.4 | ug.mL-1 | Inhibition of cytopathogenicity against human HIV-2(LAV-2) in MT-4 cells | CHEMBL1134666 | |
NAs.002027 | 2 | all-match | Unchecked | ![]() |
Other | > | 21.0 | % | Inhibitory effects on HSV-1 induced mortality in NMRI mice upon (ip) administration at a dose of 100 mk/kg/day | CHEMBL1134666 |